drugset / Trial / NCT01932788

Preventing Health Disparities During Pregnancy Through Vitamin D Supplementation

NCT01932788

RandomizedParallel-groupQuadruple-blindPrevention

Summary

The purpose of this study is to give all mothers the best chance for a healthy pregnancy through vitamin D supplementation. We will study women of diverse racial/ethnic backgrounds who will receive either the current vitamin D standard of 400 IU/day (in the prenatal vitamin) or 4000 IU/day (dose found in previous pregnancy studies to achieve vitamin D sufficiency). This research is sponsored by the W.K. Kellogg Foundation and the Medical University of South Carolina. The purpose of this study is to examine the effectiveness and infection-fighting properties of the body in relationship to vitamin D levels. This study is being done at the Medical University of South Carolina (MUSC) clinics, and will involve approximately 450 volunteers.

Timeline

Start
2013-01
Primary completion
2017-04-30
Completion
2018-04-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cholecalciferol Other / unclassified 4000 iu Oral

Indications